Category:Antiplatelet drugs - Revision history

Zeki at 02:52, 27 June 2024

2024-06-27T02:52:24Z

← Older revision		Revision as of 22:52, 26 June 2024
Line 1:		Line 1:
	[[Category:Cardiovascular Drug]]		[[Category:Cardiovascular Drug]]

	'''Antiplatelet drugs'''（中文：[[:Category: 抗血小板藥 \| 抗血小板藥]]		'''Antiplatelet drugs'''（中文：[[:Category: 抗血小板藥 \| 抗血小板藥]]）

	Platelet aggregation is important in haemostasis and is also involved in thrombus formation, particularly in the arterial circulation. Antiplatelet drugs reduce platelet aggregation and are used to prevent further thromboembolic events in patients who have suffered myocardial infarction, ischaemic stroke or transient ischaemic attacks, or unstable angina, and for primary prevention of a thromboembolic event in patients at risk.		Platelet aggregation is important in haemostasis and is also involved in thrombus formation, particularly in the arterial circulation. Antiplatelet drugs reduce platelet aggregation and are used to prevent further thromboembolic events in patients who have suffered myocardial infarction, ischaemic stroke or transient ischaemic attacks, or unstable angina, and for primary prevention of a thromboembolic event in patients at risk.

	Antiplatelet drugs act through a wide range of mechanisms. Aspirin is the most widely used. It acts by irreversibly inhibiting platelet cyclo-oxygenase and thus preventing synthesis of thromboxane A2.		Antiplatelet drugs act through a wide range of mechanisms. Aspirin is the most widely used. It acts by irreversibly inhibiting platelet cyclo-oxygenase and thus preventing synthesis of thromboxane A2.

Zeki at 02:52, 27 June 2024

2024-06-27T02:52:15Z

← Older revision		Revision as of 22:52, 26 June 2024
Line 1:		Line 1:
	[[Category:Cardiovascular Drug]]		[[Category:Cardiovascular Drug]]

	'''Antiplatelet drugs'''		'''Antiplatelet drugs'''（中文：[[:Category: 抗血小板藥 \| 抗血小板藥]]

	Platelet aggregation is important in haemostasis and is also involved in thrombus formation, particularly in the arterial circulation. Antiplatelet drugs reduce platelet aggregation and are used to prevent further thromboembolic events in patients who have suffered myocardial infarction, ischaemic stroke or transient ischaemic attacks, or unstable angina, and for primary prevention of a thromboembolic event in patients at risk.		Platelet aggregation is important in haemostasis and is also involved in thrombus formation, particularly in the arterial circulation. Antiplatelet drugs reduce platelet aggregation and are used to prevent further thromboembolic events in patients who have suffered myocardial infarction, ischaemic stroke or transient ischaemic attacks, or unstable angina, and for primary prevention of a thromboembolic event in patients at risk.

	Antiplatelet drugs act through a wide range of mechanisms. Aspirin is the most widely used. It acts by irreversibly inhibiting platelet cyclo-oxygenase and thus preventing synthesis of thromboxane A2.		Antiplatelet drugs act through a wide range of mechanisms. Aspirin is the most widely used. It acts by irreversibly inhibiting platelet cyclo-oxygenase and thus preventing synthesis of thromboxane A2.

Helen at 07:59, 5 August 2022

2022-08-05T07:59:43Z

← Older revision		Revision as of 03:59, 5 August 2022
Line 1:		Line 1:
	[[Category:Cardiovascular Drug]]		[[Category:Cardiovascular Drug]]

			'''Antiplatelet drugs'''

	Platelet aggregation is important in haemostasis and is also involved in thrombus formation, particularly in the arterial circulation. Antiplatelet drugs reduce platelet aggregation and are used to prevent further thromboembolic events in patients who have suffered myocardial infarction, ischaemic stroke or transient ischaemic attacks, or unstable angina, and for primary prevention of a thromboembolic event in patients at risk.		Platelet aggregation is important in haemostasis and is also involved in thrombus formation, particularly in the arterial circulation. Antiplatelet drugs reduce platelet aggregation and are used to prevent further thromboembolic events in patients who have suffered myocardial infarction, ischaemic stroke or transient ischaemic attacks, or unstable angina, and for primary prevention of a thromboembolic event in patients at risk.

	Antiplatelet drugs act through a wide range of mechanisms. Aspirin is the most widely used. It acts by irreversibly inhibiting platelet cyclo-oxygenase and thus preventing synthesis of thromboxane A2.		Antiplatelet drugs act through a wide range of mechanisms. Aspirin is the most widely used. It acts by irreversibly inhibiting platelet cyclo-oxygenase and thus preventing synthesis of thromboxane A2.

Helen: Created page with "Category:Cardiovascular Drug Platelet aggregation is important in haemostasis and is also involved in thrombus formation, particularly in the arterial circulation. Antip..."

2022-08-05T07:58:17Z

Created page with "Category:Cardiovascular Drug Platelet aggregation is important in haemostasis and is also involved in thrombus formation, particularly in the arterial circulation. Antip..."

New page

[[Category:Cardiovascular Drug]]

Platelet aggregation is important in haemostasis and is also involved in thrombus formation, particularly in the arterial circulation. Antiplatelet drugs reduce platelet aggregation and are used to prevent further thromboembolic events in patients who have suffered myocardial infarction, ischaemic stroke or transient ischaemic attacks, or unstable angina, and for primary prevention of a thromboembolic event in patients at risk.

Antiplatelet drugs act through a wide range of mechanisms. Aspirin is the most widely used. It acts by irreversibly inhibiting platelet cyclo-oxygenase and thus preventing synthesis of thromboxane A2.